Sergio Luquero‐Bueno
Impact in
-
- Long-Term Effects of COVID-19
- Neuroinflammation and Neurodegeneration Mechanisms
-
- COVID-19 Clinical Research Studies
Papers in
- Oncology 3
- Drug Transport and Resistance Mechanisms 2
- Inflammatory Biomarkers in Disease Prognosis 1
- Co-authors
- José Curbelo (7 shared papers)A. Lancho (6 shared papers)José María Galván‐Román (7 shared papers)Javier Aspa (5 shared papers)Olga Rajas (4 shared papers)Hortensia de la Fuente (4 shared papers)Lorena Vega‐Piris (3 shared papers)Julio Ancochea (2 shared papers)
In The Last Decade
Sergio Luquero‐Bueno
16 papers receiving 258 citations
Peers
Comparison fields: 5 of 61
- Neurology 31
- Infectious Diseases 39
- Neurology 17
- Epidemiology 65
- Obstetrics and Gynecology 13
Countries citing papers authored by Sergio Luquero‐Bueno
This map shows the geographic impact of Sergio Luquero‐Bueno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Luquero‐Bueno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Luquero‐Bueno more than expected).
Fields of papers citing papers by Sergio Luquero‐Bueno
This network shows the impact of papers produced by Sergio Luquero‐Bueno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Luquero‐Bueno. The network helps show where Sergio Luquero‐Bueno may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergio Luquero‐Bueno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 121 | |
| 2 | 2022 | 42 | |
| 3 | 2019 | 19 | |
| 4 | 2020 | 18 | |
| 5 | 2019 | 18 | |
| 6 | 2023 | 11 | |
| 7 | 2022 | 8 | |
| 8 | 2014 | 7 | |
| 9 | 2022 | 7 | |
| 10 | 2019 | 4 | |
| 11 | 2023 | 2 | |
| 12 | 2025 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2018 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2020 | 0 |
About Sergio Luquero‐Bueno
Sergio Luquero‐Bueno is a scholar working on Molecular Biology, Oncology, Epidemiology, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 262 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Pneumonia and Respiratory Infections (3 papers), Drug Transport and Resistance Mechanisms (2 papers), COVID-19 Clinical Research Studies (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Hormonal Regulation and Hypertension (2 papers), Circadian rhythm and melatonin (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Neurology (31 citations), Infectious Diseases (39 citations), Neurology (17 citations), Epidemiology (65 citations) and Obstetrics and Gynecology (13 citations). Sergio Luquero‐Bueno has collaborated with scholars based in Spain, Tunisia and Austria. Frequent co-authors include José Curbelo, A. Lancho, José María Galván‐Román, Javier Aspa, Olga Rajas, Hortensia de la Fuente, Lorena Vega‐Piris, Julio Ancochea, Ana Garcia Diaz and Carmen Suárez. Their work appears in journals such as Pharmaceuticals, Molecular Therapy — Nucleic Acids, PLoS ONE, Journal of Advanced Nursing and Journal of Personalized Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.